Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00280813 · ClinicalTrials.gov registry record · NA
Alcohol Use Disorders in Schizophrenia
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT00280813 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 54 participants.
The verdict
NCT00280813, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate a new treatment to help patients who have problems because of their use of alcohol. The treatment is called Behavioral Treatment for Alcohol Abuse in Schizophrenia (BTAAS).We are interested in determining whether BTAAS is more effective in reducing use than a supportive control treatment.
Interventions
- BEHAVIORAL Supportive Treatment in Addiction Recovery (STAR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2004-03 |
| Est. Completion | 2007-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00280813
The ClinicalTrials.gov registry entry for NCT00280813 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Supportive Treatment in Addiction Recovery (STAR) is the first listed.
NCT00280813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00280813 about?
NCT00280813 is a clinical study titled "Alcohol Use Disorders in Schizophrenia". The purpose of the study is to evaluate a new treatment to help patients who have problems because of their use of alcohol. The treatment is called Behavioral Treatment for Alcohol Abuse in Schizophrenia (BTAAS).We are interested in determining whether BTAAS is more effective in reducing use than a ...
What is the current status of trial NCT00280813?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2004-03. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00280813?
The interventions under investigation include: Supportive Treatment in Addiction Recovery (STAR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00280813?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.